guidelines for glp 1 drugs Your guide to GLP-1 side effects The expanding landscape of GLP-1

Several are already available in retail pharmacies at prices 60 per cent to 90 per cent lower than those of international brands, prompting Novo Nordisk to cut prices of Ozempic and Wegovy in India by 36 per cent to 48 per cent this week

Cardiovascular Safety Studies With DPP-4 Inhibitors The Clinical Guidance for Pharmaceutical IndustryDiabetes MellitusEvaluating Cardiovascular Risk in New Antidiabetic Therapies to Treat Type 2 Diabetes established by the FDA in 2008 as a consequence of adverse safety signals of rosiglitazone has set up the requirement for novel diabetes medications to prove cardiovascular safety of these substances in comparison to standard therapy under glycaemic equipoise

Should clinicians prescribe GLP-1 medications for Parkinsons disease now

Last reviewed: June 30, 2026 Last updated: June 30, 2026 Written by: Jay Hastings, CEO of PlexusDx Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations

Deborah Horn, DO, MPH, of McGovern Medical School at UTHealth Houston, led the work and said the results offer hope for people who need more options